- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
Clinical trial condition
Communicable Diseases
Explore clinical trials studying Communicable Diseases. Study availability and eligibility vary by location and protocol.
9,173 public trials
550 recruiting studies
Communicable Diseases trial results
NCT00257621
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Fort Lauderdale, Florida, United States
NCT01053741
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Johns Hopkins University Drug Development Unit Baltimore, Maryland, United States
NCT00082394
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
- Locations
-
- GSK Investigational Site Bakersfield, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Oakland, California, United States
- GSK Investigational Site San Francisco, California, United States
Completed
Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
NCT00968630
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +18 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00112593
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +281 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02294682
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Communicable Diseases, +8 more
- Locations
-
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Palm Springs, California, United States
Completed
A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)
NCT00414050
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
Not specified
NCT01097655
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
Not specified
NCT02301507
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- Thomas Street Health Center Houston, Texas, United States